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Abstract
The development of solid tumors is associated with acquisition of complex genetic
alterations, indicating that failures in the mechanisms that maintain the integrity of the
genome contribute to tumor evolution. Thus, one expects that the particular types of genomic
alterations seen in tumors reﬂect underlying failures in maintenance of genetic stability, as well
as selection for changes that provide growth advantage. In order to investigate genomic
alterations we are using microarray-based comparative genomic hybridization (array CGH).
The computational task is to map and characterize the number and types of copy number
alterations present in the tumors, and so deﬁne copy number phenotypes and associate them
with known biological markers.
To utilize the spatial coherence between nearby clones, we use an unsupervised hidden
Markov models approach. The clones are partitioned into the states which represent the
underlying copy number of the group of clones. The method is demonstrated on the two cell
line datasets, one with known copy number alterations. The biological conclusions drawn
from the analyses are discussed.
r 2004 Elsevier Inc. All rights reserved.
AMS 2000 subject classifications: 92-08
Keywords: HMM; Array CGH; MMR; Chromosomal aberrations; Genomic proﬁle; Mutation; Cancer
ARTICLE IN PRESS
Corresponding author. Fax: +415-502-3179.
E-mail address: janef@cc.ucsf.edu (J. Fridlyand).
URL: http://www.cc.ucsf.edu/jainlab/people.
0047-259X/$ - see front matter r 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jmva.2004.02.008
1. Introduction
Tumors are driven by an accumulation of genetic and epigenetic changes resulting
in altered levels of expression of certain genes, thereby modifying normal cell growth
and survival. Many of these changes involve gains and/or losses of parts of the
genome and are frequently observed in many different types of cancers. In order for
a cell to become malignant, one or more mechanisms that normally maintain genome
integrity and/or regulate cell division must be compromised, presumably through
mutations that occur early in tumorogenesis. The relationship between DNA copy
number and the transcriptional activity of the genes mapped to altered regions has
been demonstrated in [14]. Moreover, gains and losses of chromosomes and
chromosomal segments are involved in developmental abnormalities.
A variety of cytogenetic and more recently array-based [6,13,19] analytic methods
have revealed a wide range in the number and types of DNA copy number
aberrations present in human and murine tumors. This is likely to be a reﬂection of
not only selection for increased growth advantage and survival, but also the different
number and types of DNA copy number aberrations could point to underlying
defective mechanism(s) permitting these aberrations.
1.1. Array CGH
Microarray-based comparative genomic hybridization (array CGH) provides a
means to quantitatively measure DNA copy number aberrations and map them
directly onto genome sequences. Typically, a test genomic DNA pool (e.g. tumor
genomic DNA) is labeled with Cy3 and a reference genomic DNA pool (e.g. normal
genomic DNA) is labeled with Cy5. The differentially labeled genomic DNA pools
are then combined with unlabeled Cot-1 DNA, which blocks repetitive sequences in
the genome, denatured and hybridized onto an array containing genomic clones.
After hybridization, digital images are captured for each of the ﬂuorescent dyes used
in the hybridization. Image analysis software is used to calculate a ratio of the
ﬂuorescence intensities for each of the array targets. This ratio of test to reference
intensity then reﬂects the relative DNA copy number between the two hybridized
specimens for a certain locus. Arrays comprised of large-insert genomic clones, such
as bacterial artiﬁcial chromosomes (BACs) provide reliable and quantitative
measurements of DNA copy number aberrations, which can range from single
copy gains and losses to homozygous deletions and high-level ampliﬁcations. The
schematic representation of array CGH is shown in Fig. 1.
Analyses of array CGH data have shown that the genomes of established tumors
are remarkably stable, as evidenced by similarity of tumor recurrences to primary
tumors [2,20]. These observations indicate that the set of aberrations is maintained
because of continued selective advantage. The dependence of the type of changes in a
tumor on its genetic background has been previously demonstrated using both gene
expression [5] and chromosomal data [18]. Desai et al . [5] demonstrated in murine
models that initiating oncogenic events determine gene expression patterns of
mammary tumors. Snijders et al. [18] showed that tumors with defects in mismatch
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repair (MMR) genes take a different genetic route to develop methotrexate
resistance than MMR proﬁcient tumors. These observations suggest that the
spectrum of alterations that one sees in fully developed tumors is a composite of
selection acting on the variation that is permitted to arise by the particular failures in
genomic surveillance mechanisms(s) present in the tumor. The relation of
mechanistic defect to aberration type has not been established for most sporadic
tumor types; however, it is likely that some of the variety and complexity associated
with these tumor genomes might be rationalized if associations could be developed
between particular aberrations and speciﬁc effects in maintenance of genome
stability. One’s hope is to eventually identify speciﬁc mechanistic failures and
corresponding drug targets depending on the gene expression or copy number tumor
proﬁle.
The karyotype of a cell is deﬁned as the chromosomal makeup of a somatic cell
including the number, arrangement, size and structure of the chromosomes. Array
CGH approach allows us to assess the number and types of dosage changes of
chromosomal segments relative to a reference which generally has a normal diploid
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Fig. 1. Schematic representation of array CGH. The test and reference DNA are labeled with two
different dyes and competitively hybridized to the array together with COT-1 DNA in order to block
repeat sequences. The ratio of the ﬂuorescence intensity for each spot is indicative of the relative copy
number of the corresponding DNA sequence in the tumor sample. For display purposes the clones are
ordered according to their mapping positions along the genome. The density of the clones on the array is
high enough (approximately every 1:4 Mb) to be able to approximate the true copy number distribution.
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karyotype. We present an automated method for identifying and characterizing
DNA copy number changes in a given sample. We distinguish four types of genomic
changes: copy number transitions indicating low-level changes within a chromosome,
whole chromosomal gains and losses, focal aberrations due to low-level alterations of
very narrow regions (o1 Mb with the current resolution) and high-level focal
amplifications. Alterations that can occur by only one biological event, for example a
single copy gain or loss, are deﬁned as ‘‘low-level’’. These result in small changes in
observed ratios. ‘‘Ampliﬁcations’’ are deﬁned as an increase in copy number of small
regions of the genome that require multiple biological events to accomplish.
Typically, these result in large ratio changes. More details on the underlying biology
of the four types of changes are given in Section 2.5. Previously, it was possible to
evaluate results of FISH and chromosomal CGH for overall number of genomic
aberrations or to search for recurrent changes. The more detailed taxonomy has
emerged only with the use of genome-wide array CGH [19] which allows one to more
accurately determine the number, types and locations of the transitions of DNA
copy number alterations throughout the genome.
The manual process of characterizing individual genomic proﬁles is time-
consuming, prone to human error and non-reproducible. Fig. 2 demonstrates the
possible range for the tumor proﬁle complexity. While manual identiﬁcation of the
genomic changes for the proﬁle (a) is straightforward, it becomes more complicated
for the proﬁle (b) and virtually impossible for (c).
With the coming abundance of array CGH data, the need for an automated
reliable algorithm is substantial. Section 2 gives a brief overview of the available
approaches and describes the application of the unsupervised hidden Markov model
(HMM) method to array CGH data. Two cell-line data sets are presented in Section
2.1 and the results are given in Section 3. Finally, Section 4 summarizes our ﬁndings
and outlines open questions.
2. Methods
For a given genomic proﬁle, the goal is to partition the clones into sets with
the same copy number and thus to characterize the copy number of the genomic
segments. The biological model underlying this approach is that genomic
rearrangements lead to gains or losses of segments of the genome, possibly
spanning entire chromosomes, or, alternatively, to focal high-level ampliﬁcations.
In particular, it is desirable to make use of the physical dependence of the
nearby clones, which translates into copy number dependence. Currently, we
are aware of two attempts at addressing this problem which have been developed
in parallel with our method. In Olshen and Venkatraman [12] the authors
develop a novel modiﬁcation of binary segmentation referred to as circular binary
segmentation to look for the change points along each chromosome that represent
the copy number transitions. Jong et al. [10] apply a genetic local search algorithm to
best segment the clones into clusters. Both methods operate on individual
chromosomes.
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In this paper, we develop an algorithm which consists of two parts. In the ﬁrst
part, we partition clones on individual chromosomes into sets with the same
underlying copy number. Often the copy number can be inferred by using
thresholding of median value of log2 of the ratio of test ðTÞ and reference intensities
ðRÞ or log2 T=R in a given set. In the second part we look to characterize individual
chromosomes according to whether there have been any copy number transitions or
whole chromosome gains or losses. We also look for focal aberrations corresponding
to the individual clones such as low level gains and losses or high level ampliﬁcations.
The parameters of the algorithm have been derived using unpublished primary
tumor data by cross-checking the results with an expert in array CGH.
2.1. Data
2.2. Cell lines
We demonstrate our approach on two publicly available cell-line data sets.
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Fig. 2. Example of varying genomic complexity in breast tumors. Proﬁles from samples may range from
those that have no genomic changes (a) to those with every single chromosome containing multiple
aberrations (c). Note that ampliﬁcations (high-level focal gains) do not have to occur in the presence of
many chromosomal changes, (c), but may arise in relatively quiet proﬁles, (b).
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The ﬁrst data set was also used by Olshen and Venkataraman [12] to show
performance of their method.
2.2.1. Coriel cell lines
To test our ability to detect the low-level gains and losses, we use data featured in
Snijders et al. [19]. (These data are freely available for download at http://
www.nature.com/ng/journal/v29/n3/suppinfo/ng754 S1.html.) The data consists of
single experiments on 15 ﬁbroblast cell lines containing cytogenetically mapped
partial or whole-chromosome aneuploidy (non-diploid copy number), and each array
contained 2276 mapped BACs spotted in triplicate.
This data set is used as a proof of principle as it consists of very pure diploid cell
lines with previously characterized genomic aberrations which are easily detectable
by manual inspection of the proﬁles. To complicate the detection task in order to be
able to optimize the parameters of the procedure and to compare the HMM
approach to the more traditional clustering partitioning methods, we generate
artiﬁcial chromosomes by adding Gaussian noise to the observed log2 T=R ratios on
the selected chromosomes.
2.2.2. MMR cell lines
The interplay between selection and genetic instability in shaping tumor genomes
is currently most clearly established in tumors with defects in MMR. These tumors
show a high level of microsatellite instability because of failures in MMR genes
(generally MSH2 or MLH1). Cytogenetic analyses have shown that tumors with
defects in MMR have fewer chromosomal changes than MMR competent solid
tumors, suggesting that a greater proportion of the alterations required for
malignancy occur in genes whose nucleotide sequences are susceptible to errors
normally corrected by this system. Array CGH was done on 10 MMR deﬁcient and
10 proﬁcient cell lines to perform a high-resolution analysis of the effect of MMR
competence on the number and types of the genomic alterations [18]. (Complete data
set is available at http://cc.ucsf.edu/albertson/public.) Our aim was to conﬁrm the
previous ﬁndings and to investigate whether differences in speciﬁc MMR genes
translate to differences in the types of genomic instability.
2.3. Data pre-processing
In an ideal measurement, the copy number of a given clone can be inferred by
considering its log2 T=R ratio. For instance, log2
3
2 ¼ 1:58 should correspond to one
copy gain and log2
1
2
¼ 1 would mean one copy loss. However, the primary task of
estimating true copy number for a given clone is complicated by many experimental
and biological factors such as purity and ploidy of a sample. The most frequent
phenomenon arising in the analysis of the primary tumors is imperfect dissection
leading to normal cell contamination. Generally, pathologists make sure that each
tumor sample contains no more than 50% or even 30% of normal cells. (The purity
of the tumor sample increases as the contamination proportion decreases.)
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Additionally, not all tumor cells may have acquired a given aberration. Finally, the
tumor cells may not be diploid, i.e. a large number of whole chromosomes are
present in more than two copies. Here we deﬁne ploidy of the sample as the copy
number of the majority of the genome. On our arrays we approximate the ploidy by
the median copy number of the loci represented on the array, typically normalized to
0 as described below. All of these factors reduce the expected magnitude of copy
number ratios and often make estimation of a true underlying copy number for a
given clone impossible. Here we only partition clones into sets of the same
underlying copy number and do not undertake the task of estimating the true copy
number corresponding to a given state.
Formally, the observed unnormalized log2 T=R ratio for a clone j in a sample i; xij ;
is determined by the true copy number of that clone in a tumor cell, cTij ; ploidy of
the reference sample, plref ; normal cell admixture, a
N
i ; ploidy of the normal (non-
tumor) cells, cNi ; and fraction of the tumor cells which have not acquired a given
aberration, tNij : Then, the proportion of the cells with a given aberration is p
aber
ij ¼
ð1 aNi Þð1 tNij Þ and
xij ¼ log2
cTij p
aber
ij þ cNi ð1 paberij Þ
plref
 !
þ eð1Þij ;
where eð1Þij is experimental error. In addition, we allow observed log2 T=R ratios on a
chromosome to be dependent, i.e. the copy number for a clone is probabilistically
related to the copy number of the physically proximal clones. Generally, the
reference sample is derived from a normal (diploid) tissue and hence has ploidy
plref ¼ 2:
Note that as with any comparative technology, proper array normalization is
necessary for meaningful multi-array analysis. We have found that no intensity or
subarray-dependent normalization [21] is necessary with arrays described in Snijders
et al. [19] and quantiﬁed using custom image analysis software Spot [9]. Instead we
normalize by the global shift of the median of the observed log2 ratios for a given
sample. The normalized observed log2 ratio is
yij ¼ log2
cTij p
aber
ij þ cNi ð1 paberij Þ
plref
 !

medianj log2
cTij p
aber
ij þ cNi ð1 paberij Þ
plref
 ! !
þ eij :
Recall that numerator of the second term approximates the ploidy of the tumor
sample, plT; and, thus,
yij ¼ log2
cTij p
aber
ij þ cNi ð1 paberij Þ
plT
 !
þ eij;
where eij is assumed to be distributed as iid Normalð0;s2i Þ with a constant variance
for all clones in a given hybridization. The distributional assumption is used in the
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likelihood calculation when ﬁtting HMMs in Section 2.4 and is supported by the
experimental data on self–self hybridizations (i.e. when a sample is compared to
itself) where all the departures of the observed values from 0 are assumed to be
experimental noise. Error variability has previously been shown to be independent of
the copy number using the experiments on the cell lines with known genetic
alterations. Note that the requirement that tumor sample ploidy is well
approximated by the median of the unnormalized log2 ratios is necessary to perform
a meaningful normalization. Also, with normalization the ploidy of the reference
sample no longer plays a role. In the rest of the paper we partition normalized
log2 T=R ratios, yij in the sets of clones with the same copy number and determine
alteration types for individual clones and chromosomal regions.
2.4. Unsupervised HMM partitioning
The HMM approach is a natural framework for the task at hand as the hidden
states represent the underlying copy number of the clones. The data going into the
model are the observed normalized log2 T=R ratios of the clones. For each
chromosome j and sample i; we independently ﬁt an HMM, determine the number of
states and allocate the clones to the derived states.
HMMs have been extensively applied to a wide range of problems [15]. A discrete
time HMM with continuous output is characterized by the following:
(1) K ; the number of states in the model. The states are hidden and, generally,
physically meaningful. Typically, the states are interconnected in a way that any
state can be reached from any other state. We denote the individual states as
S ¼ S1;y; SK and the state at the location l as sl ; 1plpL:
(2) The initial state distribution p ¼ fpkg where
pk ¼ Pfs1 ¼ Skg; 1pkpK :
(3) The state transition probability distribution A ¼ fampg where
amp ¼ Pfslþ1 ¼ Spjsl ¼ Smg; 1pm; ppK :
For the special case of a model in which all states are connected, amp40 for all
m; p:
(4) The emission distribution or probability density function B ¼ fbkðOÞg where
fbkðOÞg ¼ GðO; lk;UkÞ; 1pkpK ;
where O is the vector being modeled, G is Gaussian density with mean vector lk
and covariance matrix Uk: More generally, G is any log-concave or elliptically
symmetric density and the probability density function fbkðOÞg is a ﬁnite
mixture (see [15]).
Thus, an HMM with the ﬁxed number of hidden states K can be characterized in
terms of three parameters: (i) the initial state probabilities, p; (ii) the transition
probability matrix, A; and (iii) the collection of Gaussian emission probability
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functions deﬁned within each state, B: The parameters of the model may be
represented in a compact way as l ¼ ðA; B; pÞ and the sequence of values on a given
chromosome is written as O ¼ ðo1;y; oTÞ:
When ﬁtting an HMM of size K to the vector of the observed log2 T=R ratios of
the clones that physically map to a given chromosome, we use the Forward-Backward
Procedure to calculate LikðljOÞ or the likelihood of the parameters given the vector
of values. To identify the optimal state sequence associated with a given vector, for
each observation ot we choose the state sl which is individually most likely. Finally we
re-estimate model parameters l ¼ ðA; B; pÞ to maximize LikðljOÞ using the Baum-
Welch method or, equivalently, the EM algorithm. It has been shown (Rabiner [15])
that while the initial estimates for p and A may be fairly arbitrary, good initial
estimates for B may be essential in the HMM with a continuous distribution output.
We set parameters for p by placing a majority of the weight on the state
corresponding to the ‘‘normal’’ (or median for a given sample) copy number (i.e.
expected value of a state output is 0) and distributing the remaining probability
uniformly among all other states. Similarly, to initialize A; we assign a high
probability of remaining in the same state and low non-zero probabilities to
transitioning between states. This results in an HMM model where all states are
connected. Finally, to estimate initial emission probabilities, we segment the
observations in K states using partitioning among medoids or PAM [11] and estimate
the mean for each state by the median of the log2 T=R ratios of the clones that were
allocated to that state. Similarly, we estimate the common initial variance for the
states in a given sample.
It remains to choose the number of states K ; 1pKpKmax: We take a heuristic
approach which minimizes
cðKÞ ¼ logðLikðljOÞÞ þ qK DðLÞ=L; K ¼ 1;y; Kmax;
where qK is the number of the parameters corresponding to the number of states, K ;
and DðLÞ is a function of the number of L clones on a chromosome. Note that
DðLÞ ¼ 2 gives AIC or Akaike’s information criterion [1] and DðLÞ ¼ logðLÞ one
obtains the Schwartz BIC or Bayesian information criterion [17].
Algorithm 1. Segment clones into sets with the same underlying copy number:

 For k ¼ 1yKmax states:
(1) Fit k-state HMM.
(2) Calculate penalized negative log-likelihood cðkÞ:

 Choose the model corresponding to the number of states with the smallest cðkÞ;
K ¼ argmink cðkÞ:

 If K ¼ 1; then STOP.

 Calculate the median for each state and identify the two states whose medians
are the closest. Compute d ¼ minKk1ak2 jmedk1  medk2 j .

 While dothreshold and K41:
(1) Merge the two closest states.
(2) Set K ¼ K  1 and recompute d:
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The parameters of the procedure are the maximum size of an HMM model, Kmax;
the model selection criterion DðLÞ and the threshold for the state merge, threshold :
The maximum number of states is limited by the number of clones on a given
chromosome and the computing time, so we have used Kmax ¼ 5: We have found
that this was generally sufﬁcient to recover the structure of even very complicated
tumor proﬁles. In Section 3.1 we describe a small simulation study comparing the
performance of AIC and BIC model size selection criteria. We conclude that AIC
followed by the merging step leads to the most satisfying results. Finally, the
threshold to merge the states should be determined by taking into account the speciﬁc
problem at hand: i.e., what the investigator believes to be the level of purity of the
populations and whether type I or type II error is more undesirable. For example, it
is acceptable to have a number of false positives when structurally characterizing
tumor proﬁles. On the other hand, one needs to be very conservative in calling the
aberrations for medical diagnostic purposes [3]. In the past, we have allowed the
threshold to be as low as 0:25 when analyzing primary tumors and as high as 0:5
when looking for genetic abnormalities homogeneously present in all cells.
Generally, lower thresholds should be used with more heterogeneous samples.
It is possible to ﬁt HMMs to all chromosomes simultaneously by constraining
state means and variances to be the same across the chromosomes. The difﬁculty of
doing this is that some copy number changes may be present in all cells in the
population, while others are present only in some of the cells. Thus aberrations at
different locations in the genome may have different ratios. Attempting to constraint
the transition matrix to be the same across chromosomes is probably biologically
even less plausible due to varying propensity for genomic instability on different
chromosomes.
2.5. Characterizing genomic aberrations
We characterize the genomic proﬁles using four types of genomic alterations: copy
number transitions, whole chromosomal gains and losses, focal aberrations and high-
level focal amplifications. Different genomic alterations are likely to be initiated by
failures in different types of mechanisms that normally maintain genome integrity
and/or regulate proper cell division. For example, gains or losses of whole
chromosomes are expected to occur following failures of karyokinesis or cytokinesis
(divisions of nucleus or cell), and copy number transitions within a chromosome are
likely to be initiated by DNA double-stranded breaks. The two types of focal
aberrations reﬂect low-level gains or losses of DNA sequence spanning less than
1 Mb (one or two clones at the current array resolution) and gene ampliﬁcations,
which we deﬁned as focal high-level copy number changes. The focal aberrations are
also a consequence of double-stranded breaks; however, there is likely to be a
mechanistic difference between the breaks leading to focal aberrations and low-level
copy gains and losses. It is believed that ampliﬁcations arise under selective pressure
to replicate the same localized event more than once. The exact mechanisms of how
different types of genomic instability arise are currently unknown; however, we have
found so far that the above taxonomy is useful and is associated with existing clinical
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phenotypes (work in progress). In particular, we demonstrate in Section 3.2 that
speciﬁc types of genomic alterations are associated with different genetic mutations.
Once the clones on each chromosome are partitioned into the states, there are still
parameters to be set by a user to assign the alteration types. We have deﬁned the
parameters in accordance with our experience with array CGH data. Examples for
each type of alteration are shown in Fig. 3. The following algorithm outlines the
procedure we use for categorizing the genomic alterations.
Algorithm 2. Assign alteration types to genomic regions and to individual clones:
(1) Estimate the sample standard deviation: Compute the median absolute
deviation (MAD) of the clones in the states containing at least 20 clones
located on the chromosomes partitioned inp3 states. The standard deviation s
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Fig. 3. Example of types of genomic aberrations. The dotted red line indicates the centromere of each
chromosome. Solid blue and dotted green lines show the ﬁrst clone after the transition and last clone
before the transition, respectively, separating the regions with constant copy number. Red and orange dots
indicate ampliﬁcations and focal aberrations. Yellow dots indicate outliers. Fig. (a) shows homozygous
deletion and 1 copy focal gain (focal aberration). Fig. (b) shows an amplicon consisting of a single clone
and 1 copy focal deletion (focal aberration). Note that the three neighboring clones are classiﬁed as
aberrations as they are placed in alternating states and the last two clones fall into the same state but are
telomeric clones. Fig. (c) shows whole chromosome loss. The structure of the chromosome in (d) is
complicated: it contains transitions (normal, one copy gain and one copy loss states), an amplicon with
complicated structure also separated by transitions and a single clone amplicon; outliers and focal
aberrations.
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is estimated as median of MADs for all such states. High s indicates poor
hybridization quality.
(2) Find outliers: Identify a clone as an outlier if its value differs from the median
value of their state byX5s: The clones that are indicated as outliers over a series
of hybridizations may represent natural copy number polymorphisms such as
repeats or length polymorphisms [3] or mismapped clones. Outliers do not
represent an alteration type but rather an auxiliary quantity used in ﬁnding
ampliﬁcations and detecting array problems.
(3) Identify focal aberrations: A clone is called a focal aberration if it is (i) a single
clone (two clones mapped to the telomere or to the ends of a chromosome)
assigned to a state different from the state of both of the neighboring clones (one
neighboring clone if at a telomere) or (ii) two or more clones mapping within
1 Mb whose states are different from the states of both of the neighboring
clones. Focal aberrations may indicate true narrow gains or deletions or,
alternatively, mismapped clones or natural copy number polymorphisms.
(4) Find transitions: Exclude clones marked as focal aberrations and place the copy
number transitions between the two regions whose states differ. The transitions
indicate the number of double-stranded breaks that occurred. The end of a
previous region and the start of a new region are placed at the last and ﬁrst
clones of the regions immediately to the left and to the right of the transition.
(5) Identify whole chromosomal changes: A chromosome is called gained (lost) if it
does not contain transitions and, after exclusion of clones that are outliers or focal
aberrations all of the following conditions hold: (i) at least 95% of the clones have
log2 T=R greater (less) than 0, (ii) the null hypothesis H0 that the mean m ¼ 0 is
rejected at p-value o0:0001 using a t-test, and (iii) the median of the log2 T=R
ratios of the clones is greater (less) than a threshold ¼ 0:1 ð0:1Þ: Note that all
the quantities here are ad hoc and the threshold is used to protect against rare but
possible sporadic behavior of the chromosomes with sparse coverage.
(6) Find focal ampliﬁcations: The magnitude, focality and relative ratio difference
are used to identify focal ampliﬁcations. A clone is ampliﬁed if any of the
following is true:

 It is an outlier and its log2 T=R is (i) greater by diffVal1 ¼ 1 than the
median value of the state containing the clone, or (ii) at least
absValSingle ¼ 1 and is greater by diffVal2 ¼ 0:5 than the median value
of the state containing the clone;

 It is an aberration and its log2 T=R is (i) greater by diffVal1 ¼ 1 than the
maximum of the median values of the two surrounding states, or (ii) greater
than absValSingle ¼ 1 and is greater by diffVal2 ¼ 0:5 than the maximum
of the median values of the two surrounding states;

 It belongs to a narrow ðo5 MbÞ region and the median value of the state to
which the clones in the region belong is greater than absValRegion41:5:
Note, that the conditions above describe a focal ampliﬁcation as a clone
whose log2 T=R is sufﬁciently high relative to its neighboring clones. In
addition, we allow multiple amplicons in the narrow regions with very high
log2 T=R (last condition).
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3. Results
3.1. Coriel cell lines
To assess the performance of our algorithm on the Coriel cell lines, we used the
table of agreement between known karyotypes and manual segmentation of the
array CGH proﬁles published by Snijders et al. [19]. There were 15 chromosomes
with partial changes and 8 whole chromosomal monosomies (1 copy) or trisomies
(three copies). In two chromosomes, the known regions of alterations contained only
one or two clones and were located at the telomeric ends. In their analysis, Snijders
et al. [19] conﬁrmed all but one of the known partial and whole chromosomal
changes. In addition they found a number of single clone aberrations that have not
been conﬁrmed by an alternative technique, such as FISH. Such localized
aberrations may be real and not previously seen because of the crude resolution of
the cytogenetic analysis. Alternatively, they could correspond to the mismapped
clones or array artifacts.
In our analysis we have detected all of the whole and partial chromosomal changes
conﬁrmed by Snijders et al. [19], and all of the transitions except the two that
occurred in the narrow telomeric regions described above. Our deﬁnition of a copy
number transition does not allow us to identify such narrow regions near the
telomere, and the clones in those regions were placed in a different state from the rest
of the clones and identiﬁed as focal aberrations. Thus, all of the known alterations
were found. Additionally, there were a number of single-clone aberrations (mean
number of aberrations per sample is 3 with range of 0 to 8) found by the algorithm.
These alterations were not evaluated by independent means. Fig. 4 shows four
examples of application of our method to the Coriel cell lines.
In this analysis we used AIC as a model selection criterion followed by a merging
step with the conservative threshold of 0.35 since we are dealing with pure diploid cell
lines and hence the expected size of one copy gain is log2ð3=2Þ ¼ 0:58 and of one copy
loss is log2ð1=2Þ ¼ 1: Interestingly, if merging was not used, additional transitions
occurring at the same chromosomal locations emerge on chromosome 11 in many
samples that separate regions with a small median log2 T=R (see Fig. 5). Those
transitions were not reproduced when the same samples were hybridized to a newer
BAC array (data not shown), i.e. we conclude that they represent an array artifact.
In comparison with our approach, the change-point method of Olshen and
Venkatraman [12] does not detect focal aberrations and it has missed a partial
chromosomal change represented by 2 clones only, but it detected all but one of the
longer partial changes that were called in [19]. One of the deletions was not detected
because of the presence of an outlier on that chromosome. The same transitions on
chromosome 11 that we have detected in the absence of merging were also found by
Olshen and Venkatraman [12].
Simulations: In choosing a model selection criterion, the question of type I error
versus type II error always arises. It is also clear that any criterion choice is
confounded by the subsequent state merge step. Here we brieﬂy address the choice of
the criterion by using a simulation approach. In addition, we investigate whether
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treating array CGH data as dependent is indeed an improvement upon simply
segmenting clones into a pre-assigned or optimized number of clusters.
Optimizing the parameters using the Coriel cell line data is difﬁcult because on
that data set any reasonable technique will do well. Instead, we generate artiﬁcial
chromosomes by repeatedly adding Gaussian noise to the chromosomes that contain
at least one transition. We investigate whether an AIC or BIC penalty gives better
results with or without the state merging step and compare the performance of
partitioning observations with HMM to PAM clustering results.
Three chromosomes each containing a monosomy or trisomy identiﬁed by a
transition were chosen for the study. Since the true karyotype is known for each of
the chromosomes, we record the ‘‘true’’ states, Ptrue; by placing the clones known to
have the same copy number in the same cluster. Each clone is assigned state ‘‘1’’ if it
has a lower copy number than the clones belonging to the other state or ‘‘2’’
otherwise. For each chromosome, we generate 150 artiﬁcial chromosomes by adding
Gaussian noise distributed as Nð0; s2Þ to each log2 T=R where s ¼ 0:1; 0:2 and 0.3
and repeating this 50 times for each s: We then partition each artiﬁcial chromosome
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Fig. 4. Application of the HMM to Coriel cell lines. Fig. (a) shows one copy gain with one transition at
the centromere. Fig. (b) contains monosomy at the telomeric end. The loss is coded as focal aberration
since there are two clones only at the telomere. Figure in lower left: trisomy created by two transitions. The
clone near the ﬁrst transition point is coded as an outlier. In Fig. (d) narrow monosomy created by two
transitions. The aberrations in the deletion region are likely to be mismapped clones.
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into states using the HMM method and choose the number of states with the AIC or
BIC criterion with or without merging. For each chromosome and s we record the
number of times that the correct number of states ð¼ 2Þ was chosen. In addition we
calculate the proportion of the clones assigned to a wrong state relative to the true
states for that chromosome. The comparison is done by permuting the labels on the
assigned states, Phmm; so that there is a maximum overlap with the true states of these
clones, Ptrue: More speciﬁcally, let RI denote the set of all permutations of the
integers 1;y; I (here I ¼ 2) and assume that there are L clones on a given
chromosome. Find the permutation tARI such thatXL
i¼1
IðtðPhmmðxiÞÞ ¼ PtrueðxiÞÞ ¼ max
tARI
XL
i¼1
IðtðPhmmðxiÞÞ ¼ PtrueðxiÞÞ;
where IðÞ is the indicator function, equaling 1 if the condition in parentheses is true,
and 0 otherwise. Then the misallocation proportion is computed as
phmm ¼ 1
XL
i¼1
IðtðPhmmðxiÞÞ ¼ Ptrueðxbi ÞÞ=L:
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Fig. 5. Coriel cell lines: chromosome 11 artifact. Note the striking similarity between the locations of
transitions in the two samples. The pattern is clearly present; however, by repeating the experiment with
the same samples on a newer version of the array with expanded clone content did not reproduce this
pattern. Thus, this pattern represents an array artifact, and motivates merging step. Note that the
difference in median log2 T=R ratios between states is less than 0.2, i.e. very small.
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Finally, we apply the PAM algorithm, with K ¼ 2 clusters to the artiﬁcial
chromosome and in the same way calculate the proportion of the clones
misallocated, ppam:
Fig. 6 shows the number of times each HMM-based method picked the correct
number of states for various noise levels. There is no difference between the methods
when the amount of noise in the data is small (s ¼ 0:1); however, the superiority of
AIC criterion combined with merging is apparent as the data becomes noisier. It is
intuitively clear that it is advantageous to ﬁrst choose a larger model and then reduce
the number of states; i.e., we ﬁrst choose a model according to a model selection
criterion with a tendency to overﬁt, such as AIC, and then follow it with the
backwards deletion step.
The result that AIC combined with merging tends to choose the correct number of
states most frequently does not ensure that the clones are allocated to the correct
states. We stratify the misallocation rate by the number of states picked by an HMM
model: 2 or 42: In each stratum we compare misallocation rates of the HMM
models and PAM.
Fig. 7 shows the disagreement rate for all chromosomes and noise levels
combinations. The advantage of utilizing dependency in the data becomes apparent
when comparing results of PAM with K ¼ 2 clusters and HMM methods: PAM has
a much higher misallocation rate as evident by the distributions shown with
boxplots. Also, misallocation rate is very similar for all HMM methods given the
number of states chosen. Thus, we can conclude that, indeed, AIC criterion with
merge is more accurate than the other methods evaluated.
3.2. MMR cell lines
Genomes of tumors with defects in MMR have few chromosomal changes
compared to most solid tumors, which are aneuploid with numerous chromo-
somal aberrations. These mainly cytogenetic observations agree with the expectation
that MMR-deﬁcient cells exhibit a higher frequency of nucleotide aberrations,
resulting in a higher probability that growth promoting alterations will occur
by mutations in genes whose nucleotide sequences are susceptible to errors
normally corrected by MMR. Here, we indirectly tested our HMM approach
to the array CGH analysis by conﬁrming known cytogenetic results on MMR cell
lines.
For each genomic proﬁle we counted the number of gains or losses of whole
chromosomes, copy number transitions within a chromosome, focal aberrations and
number of chromosomes containing high level focal ampliﬁcations (see Fig. 8). In
agreement with previous studies, we conﬁrmed that MMR-deﬁcient cells exhibited
signiﬁcantly fewer alterations relative to MMR-proﬁcient cells in accord with earlier
observations. However, we observed a substantial number of alterations in some
MMR-deﬁcient lines. We performed two-sided Wilcoxon rank tests to compare the
number of alterations by type between MMR deﬁcient and MMR proﬁcient cell lines
and obtained signiﬁcant differences (wilcoxon rank test p-value o0:05) for
comparison of copy number transitions, focal aberrations and number of
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chromosomes containing one or more ampliﬁcations. The distribution of whole
chromosomal changes was the same in all MMR subtypes. We also found a possible
dependency of aberration type on the speciﬁc MMR defect. Cells deﬁcient in MLH1
had a higher frequency of transitions, focal aberrations and ampliﬁcations than
MSH2 deﬁcient cells.
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Fig. 6. Number of times the correct number of states is picked by each model. Fifty artiﬁcial
chromosomes were generated for each of 3 3 combination. The performance of all four methods (AIC or
BIC criterion with or without state merge) is equivalent (perfect) with small amount of noise ðs ¼ 0:1Þ: As
the amount of noise increases, AIC criterion with state merge appears as a uniform winner with the largest
number of times that correct number of states are picked.
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4. Discussion, conclusions and work in progress
We have developed a method for automatic identiﬁcation of structural
abnormalities in tumor genomes using array CGH data. Here, we apply this
method to two data sets and obtain results that clearly show that our approach is
ARTICLE IN PRESS
Fig. 7. Distribution of misallocation rates produced by different methods. The dotted horizontal line
indicates misallocation rate if all clones were placed in the same state. We show distributions of all 3 3
combinations and all models stratifying by whether 2 or 3þ states were chosen by a corresponding HMM
model. The performance of all HMM methods is very close given number of states chosen. The
misallocation rate for the PAMmethod with 2 clusters underperforms all HMMmethods and is frequently
higher than the misallocation rate would be if all clones were placed in the same state.
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ﬁnding real alterations and is useful for classifying genomic proﬁles. Currently we
are applying this methodology to primary breast cancer data to investigate the
relationship of the frequencies and types of copy number alterations with defects in
mechanisms that preserve genomic integrity.
Quantitative analysis of microarray data needs to include knowledge of the
underlying biological processes. One of the main difﬁculties of developing
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Fig. 8. Distribution of aberrations in MMR cell lines. Black refers to unknown MMR deﬁciency, yellow is
MSH6, green is MSH2, red is MLH1 deﬁciency; and, ﬁnally, blue shows MMR proﬁcient cell lines.
The p-value is computed using the 2-sided wilcoxon rank sum test for equality between deﬁcient and
proﬁcient cell lines. Proﬁcient cell lines contain signiﬁcantly more aberrations of each type except for
whole chromosomal changes. MLH1 deﬁcient cell lines have more alterations that MSH2/MSH6 deﬁcient
ones.
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quantitative methods for microarray data in general and array CGH data in
particular is the lack of data sets with available ground truth. Thus it is not
possible to make decisions only on a strictly mathematical basis. The appropriate-
ness of the developed methodology can only be known in the long run on the
grounds that the conclusions demonstrate utility for improving biological
understanding and clinical decisions. For example, identiﬁcation of an amplicon
at 20q13.2 has led to a discovery of the novel oncogene, ZNF217 [4]. With
the abundance of incoming array CGH data, the need for an automatic
reliable algorithm is substantial, and the unsupervised HMM approach described
in this paper is one possible algorithm for meeting the growing demand
for interpreting genomic proﬁles. While the deﬁnition of alteration types is
subjective and is based on the suggestions and experience of biologists, this
summary approach to the proﬁles does correlate with the existing clinical
phenotypes. Note that single clone aberrations need to be interpreted with extreme
caution and whenever possible conﬁrmed using a replicate hybridization or an
alternative technique.
One interesting question related to biological mechanism is whether transitions
occur at the identical locations in multiple samples. Recurrent locations may indicate
fragile sites in the genome (heritable sensitive regions of chromosomes associated
with chromosome breakage and other aberrations) or point to the mechanism of
chromosomal abnormality. We are currently investigating recurrent locations of the
transitions in primary breast tumors.
General genomic instability has been suggested to be associated with bad
prognosis for cancer patients [7]. The overall number of genomic aberrations,
possibly stratiﬁed by subtypes, can serve as a good measure of genomic complexity
of a given tumor. We have already seen in prostate and breast primary tumor data
sets that there is indeed a relation between the number of aberrations and time to
recurrence or death (unpublished data).
We hope to further develop our approach by incorporating distance between
clones in the transition probability and, thus, allowing for the analysis of arrays with
uneven distribution of clones across the genome. We are also working to reduce
reliance on user-deﬁned thresholds and develop more objective methods for merging
states and for declaring chromosomal gain or loss.
We would also like to adapt the output of the HMM partitioning method to more
standard discrimination tasks such as clustering and discrimination. An interesting
application of HMMs to the analysis of gene expression time course data was
proposed by Schliep et al. [16]. There they used a model-based approach to clustering
the time series where each cluster is represented by an HMM. A similar idea may
work with the array CGH proﬁles.
The HMM approach may also help with identifying individual clones or
regions with differential copy number between groups of interest by reducing
the test multiplicity. For instance, each clone can be assigned the predicted value of
its state thus reducing the dimensionality of the problem and possibly making it
easier to discover interacting clusters of clones located physically apart on the
genome.
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5. Software
All the analyses in the manuscript were performed using open source R packages
[8] which may be downloaded from the Comprehensive R Archive Network (http://
cran.r-project.org) or the Bioconductor Web site (http://www.bioconductor.org).
Hidden Markov models: The hidden function from the repeated package can be
used for ﬁtting of discrete HMMs. The package can be downloaded from J. Lindsey
website www.luc.ac.be/~jlindsey/rcode.html.
Partitioning around medoids: The pam function from the cluster package is used
for partitioning around medoids clustering.
Characterizing genomic alterations: The set of utility functions for ﬁnding
alterations is available from the authors on request.
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